CD8A and neoplasm: Significantly higher percentages of tumor-infiltrating CD103+ T cells were CD8+ (mean 62.0%, figure 3G) than CD4+ (mean 34.8%, p<0.0001), CD4+FOXP3+ (mean 1.4%, p<0.0001) and CD4+FOXP3− (33.0%, p=0.0009).